Peter Eckman, MD Minneapolis Heart Institute Foundation

Peter Eckman, MD

Heart Failure Specialist

Peter Eckman, MD is a researcher at the Minneapolis Heart Institute Foundation®, and cardiologist and heart failure section head at the Minneapolis Heart Institute® at Abbott Northwestern Hospital. He graduated from the University of Minnesota Medical School and completed fellowships at the University of Minnesota Medical School and Cleveland Clinic. Dr. Eckman is board certified in advanced heart failure and transplant cardiology, cardiovascular medicine and internal medicine.

Dr. Eckman is proud to be a heart failure specialist and describes his philosophy of care as follows, “As a cardiologist, I am honored to have the opportunity to help patients feel better and live longer. I make it my priority to provide outstanding care and work hard to be accessible, thorough, honest, patient, and easy to understand. I will include your other doctors in your care plan and I respect each patient and their decisions.”

Back to Heart Failure Team

Peter Eckman, MD Minneapolis Heart Institute Foundation
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.